Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket

Immunogenetics

Volumn 43, Issue 5, 1996, Pages 268-276

  Kikuchi, Akiko ^a   Sakaguchi, Takashi ^a   Miwa, Kiyoshi ^b   Takamiya, Yuji ^a   Rammensee, Hans Georg ^c   Kaneko, Yutaro ^b   Takiguchi, Masafumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b AJINOMOTO CO INC   (Japan)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; HLA B ANTIGEN; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; ASSAY; CONTROLLED STUDY; PRIORITY JOURNAL; PROTEIN BINDING; STRUCTURE ACTIVITY RELATION;

EID: 0030031623     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02440994     Document Type: Article

References (37)

1. Baricordi, O. R., Sensi, A., Pivettipezzi, P., Perrone, S., Balboni, A., Catarinelli, G., Filippi, F., Melchiorri, L., Moncada, A., and Mattiuz, P. L. Behçet's disease associated with HLA-B51 and DRw52 antigens in Italians. Hum Immunol 17: 297-301, 1986
2. Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., and Wiley, D. C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329: 506-512, 1987
3. Bouvier, M., and Wiley, D. C. Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 265: 398-402, 1994
4. Colbert, R. A., Rowland-Jones, S. L., McMichael, A. J., and Frelinger, J. A. Differences in peptide presentation between B27 subtypes: The importance of the P1 side chain in maintaining high affinity peptide binding to B*2703. Immunity 1: 121-130, 1994
5. 2m gene expression. J Clin Invest 87: 284-292, 1991
6. Falk, K., Rötzschke, O., Stevanović, S., Jung, G., and Rammensee, H.-G. Allele-specific motifs revealed by sequencing of self- peptides eluted from MHC molecules. Nature 351: 290-296, 1991
7. Falk, K., Rötzschke, O., Grahovac, B., Schendel, D., Stevanović, S., Jung, G., and Rammensee, H.-G. Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics 38: 161-162, 1993
8. Falk, K., Rötzschke, O., Takiguchi, M., Grahovac, B., Gnau, V., Stevanović, S., Jung, G., and Rammensee, H.-G. Peptide motifs of HLA-A1, -A11, -A31 and -A33 molecules. Immunogenetics 40: 238-241, 1994
9. Falk, K., Rötzschke, O., Takiguchi, M., Gnau, V., Stevanović, S., Jung, G., and Rammensee, H.-G. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behçet's disease. Int Immunol 7: 223-228, 1995
10. Guo, H.-C., Jardetzky, T. S., Garrett, T. P. J., Lane, W. S., Strominger, J. L., and Willey, D. C. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360: 364-366, 1992
11. Hayashi, H., Ennis, P. D., Ariga, H., Salter, R. D., Parham, P., Kano, K., and Takiguchi, M. HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the α1 domain. J Immunol 142: 306-311, 1989
12. Hill, A., Takiguchi, M., and McMichael, A. Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the α2 domain. Immunogenetics 37: 95-101, 1993
13. Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R., and Wiley, D. C. Identification of self peptides bound to purified HLA-B27. Nature 353: 326-329, 1991
14. Kawaguchi, G., Hildebrand, W. H., Hiraiwa, M., Karaki, S., Nagao, T., Akiyama, N., Uchida, H., Kashiwase, K., Akaza, T., Williams, R. C., Juji, T., Parham, P., and Takiguchi, M. Two subtypes of HLA-B51 differing by substitution at position 171 of the α2 helix. Immunogenetics 37: 57-63, 1992
15. Kawaguchi, G., Nakayama, S., Nagao, T., and Takiguchi, M. A single amino acid substitution at residue 167 forms a novel HLA-B51 subtype. Tissue Antigens 42: 39-41, 1993
16. Madden, D. R., Corga, J. C., Strominger, J. L., and Wiley, D. C. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353: 321-325, 1991
17. Madden, D. R., Garboczi, D. N., and Wiley, D. C. The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75: 693-708, 1993
18. Matsumoto, K., Yamamoto, J., Hiraiwa, M., Kano, K., and Takiguchi, M. Discrimination of HLA-B5 crossreactive group antigens by human allospecific CTL clones. Transplantation 49: 1164-1167, 1990
19. Matsumura, M., Fremont, D. H., Peterson, P. A., and Wilson, I. A. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257: 927-934, 1992
20. Mizuki, N., Inoko, H., Ando, H., Nakamura, S., Kashiwase, K., Akaza, T., Fujino, Y., Masuda, K., Takiguchi, M., and Ohno, S. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B*5101. Am J Ophthal 116: 406-409, 1993
21. Mizuki, N., Inoko, H., Ishihara, M., Ando, H., Nakamura, S., Nishino, M., and Ohno, S. A complete type patient with Behçet's disease associated with HLA-B*5102. Acta Ophthalmol 72: 757-758, 1994
22. Nakayama, S., Kawaguchi, G., Karaki, S., Nagao, T., Uchida, H., Kashiwase, K., Akaza, T., Nasuno, T., and Takiguchi, M. Effect of single amino acid substitution at residue 167 of HLA-B51 on binding of antibodies and recognition of T-cells. Hum Immunol 39: 211-219, 1994
23. Nokihara, K., Yamamoto, R., Hazama, M., Wakizawa, O., and Nakamura, S. Design and applications of a novel simultenous multiple solid-phase pcptide synthesizer. In R. Epton (ed): Innovation and Perspectives in Solid-Phase Synthesis, pp. 445, Intercept, Andover, 1992
24. Ohno, S., Aoki, K., Sugiura, S., Nakajima, E., Itakura, K., and Aizawa, M. HL-A5 and Behçhet's disease. Lancet 2: 1383-1384, 1973
25. Ohno, S., Asanuma, T., Sugiura, S., Wakisaka, A., and Aizawa, M. HLA-Bw51 and Behçet's disease. J Am Med Assoc 240: 529, 1978
26. Ooba, T., Hayashi, H., Karaki, S., Tanabe, M., Kano, K., and Takiguchi, M. The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms. Immunogenetics 30: 76-80, 1989
27. Parham, P., Adams, E. J., and Arnett, E. L. The origins of HLA-A, B, C polymorphism. Immunol Rev 143: 143-180, 1995
28. Parker, K. C., Becnarek, M. A., and Coligan, J. E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152: 163-175, 1994
29. Parker, K. C., Bednarek, M. A., Hull, L. K., Utz, Y., Cunningham, B., Zweerink, H. J., Biddison, W. E., and Coligan, J. E. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J Immunol 149: 3580-3587, 1992
30. Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M., and Sette, A. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74: 929-937, 1993
31. Saper, M. A., Bjorkman, P. J., and Wiley, D. C. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J Med Biol 219: 277-319, 1991
32. Schönbach, C., Ibe, M., Shiga, H., Takamiya, Y., Miwa, K., Nokihara, K., and Takiguchi, M. Fine turning of peptide binding to HLA-B*3501 molecules by nonanchor residues. J Immunol 154: 5951-5958, 1995
33. Tait, B. D., Naito, S., Boyle, A., Dupont, E., Andrien, M., Saitou, S., Miller, S., Scorza, R., Kalil, J., Grumet, C., Pitchappau, R. M., Bias, W., Cantwell, L., Bennett, G., Zachary, A., Garrido, F., and Maeda, H. Antigen Society no. 105: HLA-B5, -B51, -B52, -B18, -B35, -B53. In K. Tsuji, M. Aizawa, and T. Sasazuki (eds.): HLA 1991, pp 297-305, Oxford, Science Publications, 1992
34. Takamiya, Y., Schönbach, C., Nokihara, K., Ferrone, S., Yamaguchi, M., Kano, K., Egawa, K., and Takiguchi, M. HLA- B*3501-peptide interactions: role of anchor residues of peptides in their binding to HLA-B*3501 molecules. Int Immunol 6: 255-261, 1994
35. Takiguchi, M., Kawaguchi, G., Sekimata, M., Hiraiwa, M., Kariyone, A., and Takamiya, Y. The role of conserve résidue in pocket A and the polymorphic residue in pocket E of HLA-B*3501 in presentation of human minor histocompatibility peptides to T- cells. Int Immunol 6: 1345-1352, 1994
36. Tanabe, M., Sekimata, M., Ferrone, S., and Takiguchi, M. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I α3 domain. J Immunol 148: 3202-3209, 1992
37. Udaka, K., Wiesmüller, K.-H., Kienle, S., Jung, G., and Walden, P. Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries. J Exp Med 181: 2097-2108, 1995